BACKGROUND: There is limited evidence on the association between socioeconomic outcomes and CD4 counts in populations that include HIV-infected adults who have high CD4 counts or have not been diagnosed. We examined this association among adults in a rural Ugandan parish. METHODS: A community health campaign offering diagnostic and treatment services for HIV and other diseases was conducted with Ministry of Health support. Data on campaign participants' education and employment were collected and a detailed household socioeconomic survey was conducted among a subset of participants. Regression analyses were used to assess relationships between CD4 count and employment and education outcomes. RESULTS: A total of 2323 adults (74% of the community) participated in the campaign; 179 of 2282 (7.8%) tested HIV-positive and 46% were newly diagnosed. Among HIV-infected adults not on antiretroviral therapy (ART), those with CD4 at least 500 worked 6.9 more days/month (P < 0.01; 39% more) and 2.5 more h per day (P < 0.05, 44% more) than those with CD4 less than 200. These effects were not significantly different from the effects for those with CD4 350-499. Children aged 6-11 years in households of adults with CD4 at least 350 did not have significantly different school enrollment rates than children in households of adults with CD4 less than 350, but differences were larger among children aged 12-18 years. CONCLUSION: Outcomes of HIV-infected adults with CD4 at least 350 were better than those of adults with CD4 less than 200 and resembled those of HIV-uninfected adults. The results suggest that early ART initiation may generate economic benefits by preventing a decline in socioeconomic status, but further research is needed to determine the CD4 threshold at which these benefits would be largest.
BACKGROUND: There is limited evidence on the association between socioeconomic outcomes and CD4 counts in populations that include HIV-infected adults who have high CD4 counts or have not been diagnosed. We examined this association among adults in a rural Ugandan parish. METHODS: A community health campaign offering diagnostic and treatment services for HIV and other diseases was conducted with Ministry of Health support. Data on campaign participants' education and employment were collected and a detailed household socioeconomic survey was conducted among a subset of participants. Regression analyses were used to assess relationships between CD4 count and employment and education outcomes. RESULTS: A total of 2323 adults (74% of the community) participated in the campaign; 179 of 2282 (7.8%) tested HIV-positive and 46% were newly diagnosed. Among HIV-infected adults not on antiretroviral therapy (ART), those with CD4 at least 500 worked 6.9 more days/month (P < 0.01; 39% more) and 2.5 more h per day (P < 0.05, 44% more) than those with CD4 less than 200. These effects were not significantly different from the effects for those with CD4 350-499. Children aged 6-11 years in households of adults with CD4 at least 350 did not have significantly different school enrollment rates than children in households of adults with CD4 less than 350, but differences were larger among children aged 12-18 years. CONCLUSION: Outcomes of HIV-infected adults with CD4 at least 350 were better than those of adults with CD4 less than 200 and resembled those of HIV-uninfected adults. The results suggest that early ART initiation may generate economic benefits by preventing a decline in socioeconomic status, but further research is needed to determine the CD4 threshold at which these benefits would be largest.
Authors: Matthew P Fox; Sydney Rosen; William B MacLeod; Monique Wasunna; Margaret Bii; Ginamarie Foglia; Jonathon L Simon Journal: Trop Med Int Health Date: 2004-03 Impact factor: 2.622
Authors: Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming Journal: N Engl J Med Date: 2011-07-18 Impact factor: 91.245
Authors: Sheri D Weiser; Reshma Gupta; Alexander C Tsai; Edward A Frongillo; Nils Grede; Elias Kumbakumba; Annet Kawuma; Peter W Hunt; Jeffrey N Martin; David R Bangsberg Journal: J Acquir Immune Defic Syndr Date: 2012-10-01 Impact factor: 3.731
Authors: Melanie A Thompson; Judith A Aberg; Pedro Cahn; Julio S G Montaner; Giuliano Rizzardini; Amalio Telenti; José M Gatell; Huldrych F Günthard; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; Peter Reiss; Douglas D Richman; Paul A Volberding; Patrick Yeni; Robert T Schooley Journal: JAMA Date: 2010-07-21 Impact factor: 56.272
Authors: Gabriel Chamie; Dalsone Kwarisiima; Tamara D Clark; Jane Kabami; Vivek Jain; Elvin Geng; Maya L Petersen; Harsha Thirumurthy; Moses R Kamya; Diane V Havlir; Edwin D Charlebois Journal: PLoS One Date: 2012-08-20 Impact factor: 3.240
Authors: Vivek Jain; Dathan M Byonanebye; Gideon Amanyire; Dalsone Kwarisiima; Doug Black; Jane Kabami; Gabriel Chamie; Tamara D Clark; James F Rooney; Edwin D Charlebois; Moses R Kamya; Diane V Havlir Journal: AIDS Date: 2014-09-24 Impact factor: 4.177
Authors: Atheendar S Venkataramani; Harsha Thirumurthy; Jessica E Haberer; Yap Boum Ii; Mark J Siedner; Annet Kembabazi; Peter W Hunt; Jeffrey N Martin; David R Bangsberg; Alexander C Tsai Journal: AIDS Date: 2014-05-15 Impact factor: 4.177
Authors: Vitor H F Oliveira; Ana L Borsari; Allison R Webel; Kristine M Erlandson; Rafael Deminice Journal: Eur J Clin Nutr Date: 2020-04-27 Impact factor: 4.016
Authors: Viviane D Lima; Harsha Thirumurthy; James G Kahn; Jorge Saavedra; Carlos F Cárceres; Alan Whiteside Journal: Clin Infect Dis Date: 2014-07 Impact factor: 9.079
Authors: Ruanne V Barnabas; Heidi van Rooyen; Elioda Tumwesigye; Justin Brantley; Jared M Baeten; Alastair van Heerden; Bosco Turyamureeba; Philip Joseph; Meighan Krows; Katherine K Thomas; Torin T Schaafsma; James P Hughes; Connie Celum Journal: Lancet HIV Date: 2016-03-10 Impact factor: 12.767
Authors: Reuben Granich; Somya Gupta; Bradley Hersh; Brian Williams; Julio Montaner; Benjamin Young; José M Zuniga Journal: PLoS One Date: 2015-07-06 Impact factor: 3.240